SCHEMBL25865793

SCHEMBL25865793

NS(=O)(=O)c1ccc(NC(NC(=O)c2ccc(Br)cc2)C(Cl)(Cl)Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
MEN1 O00255 6/20 0.58
KMT2A Q03164 6/20 0.58
MAPT P10636 4/20 0.58
LMNA P02545 4/20 0.58
NPSR1 Q6W5P4 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
HTT P42858 4/20 0.55
GAA P10253 1/20 0.55
POLB P06746 1/20 0.55
CA2 P00918 9/20 0.54
CA1 P00915 8/20 0.54
CA9 Q16790 5/20 0.54
SMN1; SMN2 Q16637 2/20 0.51
ATM Q13315 1/20 0.50
CA12 O43570 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1922849 0.83 MEN1 (0.61) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL1923339 0.82 MAPT (0.73) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL12156708 0.82 KMT2A (0.70) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL12156716 0.81 MEN1 (0.59) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL12156714 0.79 KMT2A (0.88) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL1164665 0.76 TRPA1 (0.53) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL1923355 0.76 MEN1 (0.69) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL1164037 0.76 KCNJ11 (0.55) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL1923171 0.75 MAPT (0.51) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL1164525 0.74 TRPA1 (0.54) ALDH1A1MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624353-B2 Methods and compositions for prime editing nucleotide sequences THE BROAD INSTITUTE, INC. (US) 2026-05-12 US disclosed
US-12624354-B2 Methods and compositions for prime editing nucleotide sequences THE BROAD INSTITUTE, INC. (US) 2026-05-12 US disclosed
US-12570972-B2 Methods and compositions for prime editing nucleotide sequences THE BROAD INSTITUTE, INC. (US) 2026-03-10 US disclosed
US-12509680-B2 Methods and compositions for prime editing nucleotide sequences THE BROAD INSTITUTE, INC. (US) 2025-12-30 US disclosed
US-20250215418-A1 METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE THE BROAD INSTITUTE, INC. (US) 2025-07-03 US disclosed
US-12281303-B2 Methods and compositions for prime editing nucleotide sequences THE BROAD INSTITUTE, INC. (US) 2025-04-22 US disclosed
US-20250115901-A2 METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES THE BROAD INSTITUTE, INC. (US) 2025-04-10 US disclosed
US-20240327872-A1 METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES THE BROAD INSTITUTE, INC. (US) 2024-10-03 US disclosed
CN-114127285-B Methods and compositions for editing nucleotide sequences 布罗德研究所股份有限公司 2024-09-10 CN disclosed
US-20240229077-A1 METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES THE BROAD INSTITUTE, INC. (US) 2024-07-11 US disclosed
US-11643652-B2 Methods and compositions for prime editing nucleotide sequences THE BROAD INSTITUTE, INC. (US) 2023-05-09 US disclosed
US-11643652-B2 Methods and compositions for prime editing nucleotide sequences THE BROAD INSTITUTE, INC. (US) 2023-05-09 US disclosed
US-11643652-B2 Methods and compositions for prime editing nucleotide sequences THE BROAD INSTITUTE, INC. (US) 2023-05-09 US disclosed
US-20230090221-A1 METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES THE BROAD INSTITUTE, INC. (US) 2023-03-23 US disclosed
US-20230078265-A1 METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES THE BROAD INSTITUTE, INC. (US) 2023-03-16 US disclosed
EP-4146804-A1 METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE The Broad Institute Inc. (US) 2023-03-15 EP disclosed
US-20220356469-A1 METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES THE BROAD INSTITUTE, INC. (US) 2022-11-10 US disclosed
US-11447770-B1 Methods and compositions for prime editing nucleotide sequences THE BROAD INSTITUTE, INC. (US) 2022-09-20 US disclosed
WO-2022162665-A1 SETDB1-MICROTUBULE INTERACTION AND USE THEREOF Ariel Scientific Innovations Ltd. (IL) 2022-08-04 WO disclosed
EP-3942042-A1 METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES The Broad Institute, Inc. (US) 2022-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624354-B2 Methods and compositions for prime editing nucleotide sequences POLM, FEN1, SSU72 ALDH1A1 4143/4885MEN1 4385/4885KMT2A 3423/4885
US-20230090221-A1 METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES PRNP, CNBP, UPF1 ALDH1A1 4592/4885MEN1 4489/4885KMT2A 3876/4885
US-20250115901-A2 METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES RNGTT, POLRMT, POLM ALDH1A1 4035/4885MEN1 4195/4885KMT2A 2920/4885
US-12281303-B2 Methods and compositions for prime editing nucleotide sequences RNGTT, POLRMT, POLM ALDH1A1 4035/4885MEN1 4195/4885KMT2A 2920/4885
US-12509680-B2 Methods and compositions for prime editing nucleotide sequences FEN1, RNGTT, POLM ALDH1A1 4095/4885MEN1 3726/4885KMT2A 3102/4885
US-11447770-B1 Methods and compositions for prime editing nucleotide sequences RNGTT, POLRMT, POLM ALDH1A1 4019/4885MEN1 4213/4885KMT2A 2878/4885
US-20230078265-A1 METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES PRNP, CNBP, TARBP1 ALDH1A1 4583/4885MEN1 4529/4885KMT2A 3779/4885
US-12624353-B2 Methods and compositions for prime editing nucleotide sequences RNGTT, FEN1, POLB ALDH1A1 4301/4885MEN1 4350/4885KMT2A 2333/4885
US-12570972-B2 Methods and compositions for prime editing nucleotide sequences RNGTT, FEN1, POLM ALDH1A1 4297/4885MEN1 4249/4885KMT2A 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.